Revalesio
WA - TacomaBiotechnology
Focus: Revalesio is a pre-revenue biotech company developing proprietary charge-stabilized nanostructure (CSN) technology for treatment of oncology and other therapeutic areas. Founded in 2019 and headquartered in Tacoma, WA, the company is in early-stage clinical development.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Revalesio
AI assessmentNot HiringNo open roles listed right now. Follow Revalesio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
13 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Electro-kinetically Modified Water
Pelvic PainClinical Trials (1)
NCT02523794Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis
N/AHelp build intelligence for Revalesio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.